`

Polaris Pharmaceuticals

Pharmaceutical Manufacturing

Specialities :
Adi-peg 20 (oncology)
Uricase-peg 20
Tnf-peg 20
And ck2 inhibitor
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Polaris Pharmaceuticals

What does Polaris pharmaceuticals do?+

Polaris Group, a privately held multinational biopharmaceutical drug company, specializes in the research and development of protein drugs to treat cancer and other debilitating diseases in humans. Polaris lead project is ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma. Polaris is collaborating with EnzymeRx in the development of Uricase-PEG 20 for the treatment of gout, tumor lysis syndrome, and other diseases related to hyperuricemia. Polaris is also researching and developing other biotherapeutic agents and has a small molecule drug program. The latter utilizes a rational structure-based approach for...

What are Polaris pharmaceuticals's specialties? +

Adi-peg 20 (oncology),uricase-peg 20,tnf-peg 20,and ck2 inhibitor

What is Polaris pharmaceuticals's industry? +

Polaris pharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Polaris pharmaceuticals's revenue? +

Polaris pharmaceuticals's revenue is 11m - 100m

What is Polaris pharmaceuticals's company size? +

Polaris pharmaceuticals has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.